Franklin Genomic Etf Forward View
| HELX Etf | USD 35.72 0.82 2.24% |
Franklin Etf outlook is based on your current time horizon.
At this time the relative strength momentum indicator of Franklin Genomic's share price is below 20 . This usually indicates that the etf is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using Franklin Genomic hype-based prediction, you can estimate the value of Franklin Genomic Advancements from the perspective of Franklin Genomic response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of Franklin Genomic Advancements on the next trading day is expected to be 34.70 with a mean absolute deviation of 0.41 and the sum of the absolute errors of 25.28. Franklin Genomic after-hype prediction price | USD 35.75 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as etf price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Franklin | Build AI portfolio with Franklin Etf |
Franklin Genomic Additional Predictive Modules
Most predictive techniques to examine Franklin price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Franklin using various technical indicators. When you analyze Franklin charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Franklin Genomic Naive Prediction Price Forecast For the 6th of February
Given 90 days horizon, the Naive Prediction forecasted value of Franklin Genomic Advancements on the next trading day is expected to be 34.70 with a mean absolute deviation of 0.41, mean absolute percentage error of 0.26, and the sum of the absolute errors of 25.28.Please note that although there have been many attempts to predict Franklin Etf prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Franklin Genomic's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Franklin Genomic Etf Forecast Pattern
| Backtest Franklin Genomic | Franklin Genomic Price Prediction | Research Analysis |
Franklin Genomic Forecasted Value
In the context of forecasting Franklin Genomic's Etf value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Franklin Genomic's downside and upside margins for the forecasting period are 33.43 and 35.96, respectively. We have considered Franklin Genomic's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Franklin Genomic etf data series using in forecasting. Note that when a statistical model is used to represent Franklin Genomic etf, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 116.7615 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.4144 |
| MAPE | Mean absolute percentage error | 0.0113 |
| SAE | Sum of the absolute errors | 25.2761 |
Predictive Modules for Franklin Genomic
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Franklin Genomic Adv. Regardless of method or technology, however, to accurately forecast the etf market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the etf market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Franklin Genomic After-Hype Price Density Analysis
As far as predicting the price of Franklin Genomic at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Franklin Genomic or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Etf prices, such as prices of Franklin Genomic, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Franklin Genomic Estimiated After-Hype Price Volatility
In the context of predicting Franklin Genomic's etf value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Franklin Genomic's historical news coverage. Franklin Genomic's after-hype downside and upside margins for the prediction period are 34.57 and 36.93, respectively. We have considered Franklin Genomic's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Franklin Genomic is very steady at this time. Analysis and calculation of next after-hype price of Franklin Genomic Adv is based on 3 months time horizon.
Franklin Genomic Etf Price Outlook Analysis
Have you ever been surprised when a price of a ETF such as Franklin Genomic is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Franklin Genomic backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Etf price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Franklin Genomic, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.01 | 1.27 | 0.00 | 0.00 | 0 Events / Month | 1 Events / Month | In a few days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
35.72 | 35.75 | 0.08 |
|
Franklin Genomic Hype Timeline
Franklin Genomic Adv is currently traded for 35.72. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Franklin is expected to increase in value after the next headline, with the price projected to jump to 35.75 or above. The average volatility of media hype impact on the company the price is insignificant. The price jump on the next news is anticipated to be 0.08%, whereas the daily expected return is currently at 0.01%. The volatility of related hype on Franklin Genomic is about 2760.87%, with the expected price after the next announcement by competition of 35.72. Given the investment horizon of 90 days the next expected press release will be in a few days. Check out Historical Fundamental Analysis of Franklin Genomic to cross-verify your projections.Franklin Genomic Related Hype Analysis
Having access to credible news sources related to Franklin Genomic's direct competition is more important than ever and may enhance your ability to predict Franklin Genomic's future price movements. Getting to know how Franklin Genomic's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Franklin Genomic may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| MEDX | Horizon Kinetics Medical | 0.04 | 1 per month | 0.81 | 0.09 | 2.33 | (1.62) | 4.47 | |
| UCC | ProShares Ultra Consumer | (0.51) | 2 per month | 0.00 | (0.05) | 3.36 | (4.33) | 9.55 | |
| QRMI | Global X NASDAQ | 0.00 | 0 per month | 0.32 | (0.05) | 0.50 | (0.57) | 1.74 | |
| RHRX | Starboard Investment Trust | (0.02) | 2 per month | 0.87 | (0.03) | 1.08 | (1.69) | 4.33 | |
| XTJL | Innovator Equity Accelerated | 0.00 | 0 per month | 0.34 | (0.01) | 0.59 | (0.69) | 2.16 | |
| RW | EA Series Trust | 0.00 | 0 per month | 0.00 | (0.10) | 1.75 | (1.73) | 3.85 | |
| BYRE | Principal Exchange Traded Funds | 0.03 | 1 per month | 0.62 | (0.03) | 0.99 | (0.92) | 2.78 | |
| DGIN | VanEck ETF Trust | 0.00 | 0 per month | 0.00 | (0.11) | 1.65 | (1.46) | 5.82 | |
| FMKT | Tidal ETF Trust | 0.00 | 0 per month | 0.00 | (0.09) | 1.60 | (1.89) | 4.72 | |
| BWTG | Brendan Wood TopGun | 0.00 | 0 per month | 0.79 | (0.01) | 0.94 | (1.13) | 3.49 |
Other Forecasting Options for Franklin Genomic
For every potential investor in Franklin, whether a beginner or expert, Franklin Genomic's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Franklin Etf price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Franklin. Basic forecasting techniques help filter out the noise by identifying Franklin Genomic's price trends.Franklin Genomic Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Franklin Genomic etf to make a market-neutral strategy. Peer analysis of Franklin Genomic could also be used in its relative valuation, which is a method of valuing Franklin Genomic by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Franklin Genomic Market Strength Events
Market strength indicators help investors to evaluate how Franklin Genomic etf reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Franklin Genomic shares will generate the highest return on investment. By undertsting and applying Franklin Genomic etf market strength indicators, traders can identify Franklin Genomic Advancements entry and exit signals to maximize returns.
| Rate Of Daily Change | 0.98 | |||
| Day Median Price | 35.72 | |||
| Day Typical Price | 35.72 | |||
| Price Action Indicator | (0.41) | |||
| Period Momentum Indicator | (0.82) |
Franklin Genomic Risk Indicators
The analysis of Franklin Genomic's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Franklin Genomic's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting franklin etf prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 0.9394 | |||
| Semi Deviation | 1.25 | |||
| Standard Deviation | 1.27 | |||
| Variance | 1.61 | |||
| Downside Variance | 1.62 | |||
| Semi Variance | 1.55 | |||
| Expected Short fall | (0.97) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Franklin Genomic
The number of cover stories for Franklin Genomic depends on current market conditions and Franklin Genomic's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Franklin Genomic is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Franklin Genomic's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Check out Historical Fundamental Analysis of Franklin Genomic to cross-verify your projections. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
The market value of Franklin Genomic Adv is measured differently than its book value, which is the value of Franklin that is recorded on the company's balance sheet. Investors also form their own opinion of Franklin Genomic's value that differs from its market value or its book value, called intrinsic value, which is Franklin Genomic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Franklin Genomic's market value can be influenced by many factors that don't directly affect Franklin Genomic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Franklin Genomic's value and its price as these two are different measures arrived at by different means. Investors typically determine if Franklin Genomic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Franklin Genomic's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.